| Industry Range | | Price / Earnings | N/A | |
| Book Value | 0.90 | |
| Earnings Per Share | -$1.41 | |
| Price To Sales Ratio | 2.38 | |
| Price To Book Ratio | 2.89 | |
| Price To Tangible Book Ratio | 3.01 | |
| Price/Cash Flow Ratio | N/A | |
| Price/Free Cash Flow Ratio | N/A | |
| Industry Range | | Market Capitalization | 115.0M | |
| Float (MRQ) | 93.07% | |
| Shares Outstanding (MRQ) | 65.9M | |
| Short Interest as a % of Float (MRQ) | 1.53% | |
| Shares Held By Institutions (MRQ) | 36.4M | |
| Industry Range | | Sales | $71.9M | |
| Gross Margin | 93.85% | |
| Net Profit Margin | -135.65% | |
| EBIT Margin | -127.62% | |
| EBITDA Margin | -119.49% | |
| Operating Margins | -127.62% | |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
| Industry Range | | Current Ratio (MRQ) | 2.92 | |
| Quick Ratio (MRQ) | 2.92 | |
| Total Debt/Equity Ratio (MRQ) | 66.78 | |
| Debt/Common Equity Ratio (MRQ) | 66.78 | |
| Industry Range | | Return on Equity | -166.29% | |
| Return on Assets | -38.58% | |
| Asset Turnover | 0.28 | |
| Receivables Turnover | 63.50 | |
| Inventory Turnover | N/A | |
| Industry Range | | EPS Growth Annual | 22.13% | |
| Dividend Yield 5 Year Average | 0.00% | |
| Current Dividend Yield | 0.00% | |
| Current Payout Ratio | N/A | |
*CTMX does not pay a dividend. The average dividend yield for companies in the Pharmaceuticals: Major industry is 2.06%